Effects of 2% IDL Lotion on Skin Hydration and Transepidermal Water Loss in Females With Dry Skin
Completed · Phase 1/Phase 2 · Has a placebo group
Conditions studied: Xerosis Cutis
In brief
This was a placebo-controlled double-blinded trial to compare effects of 2% IDL lotion to placebo in female subjects with dry skin. Primary endpoints were skin hydration (NovaMeter) and transepidermal water loss (VapoMeter).
Key facts
- Study ID
- NCT04253704
- Run by
- Shyla Cantor
- People needed
- 16
- Starts
- 2017-02-13
- Expected to finish
- 2017-03-03
- Last updated by the study team
- 2020-02-05
Who can join
Age: 35 and older, up to 57. Sex: female. Healthy volunteers: not accepted.
You may qualify if…
- Females who were thirty-five to fifty-seven years of age.
- Individuals free of any dermatological or systemic disorder, which would have interfered with the results, at the discretion of the investigator.
- Individuals who had completed a preliminary medical history mandated by Cantor Research Laboratories, Inc.
- Individuals who had read, understood and signed an informed consent document as required by Reference 21 CFR Ch. 1 Part 50, Subpart B. Consent forms are kept on file and are available for examination on the premises of Cantor Research Laboratories, Inc., only.
- Individuals who had abstained from the use of all moisturizing products for at least one week prior to treatment conditions.
- Individuals with known dry skin.
You may not qualify if…
- Individuals who were under doctor's care.
- Individuals who were taking medication, which in the opinion of the investigator would have masked or interfered with the results.
- Individuals with chronic skin allergies.
- Females who were pregnant or lactating.
Where it is running
- Cantor Research Laboratory — Blauvelt, New York, United States
Full record on ClinicalTrials.gov
Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.